🏅 FDA Orphan Designation

Metrogel

Metronidazole (topical)

Manufacturer: Galderma Laboratories, Inc.

Indicated for:

Mixed neuroendocrine and non-neuroendocrine neoplasm of pancreasOrphan

FDA-Approved Indications (1)

Mixed neuroendocrine and non-neuroendocrine neoplasm of pancreasOrphan Designation

Indications & Usage

1 INDICATIONS AND USAGE METROGEL, 1% is indicated for the topical treatment of inflammatory lesions of rosacea. METROGEL, 1% is a nitroimidazole indicated for the topical treatment of inflammatory lesions of rosacea. ( 1 )

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.